*  Exposure Controls/Personal Protection  *
Respiratory Protection:IF VAPOR CONCENTRATION EXCEEDS THE TLV, USE
    NIOSH/MSHA APPROVED RESPIRATOR WITH ORGANIC CHEMICAL CARTRIDGE.
    CONTACT A REPUTABLE SAFETY SUPPLY COMPANY FOR THE APPROPRIATE
    RESPIRATOR.
Ventilation:USE APPLICABLE ENGINEERING CONTROLS, WORK PRACTICES, &
    PERSONAL PROTECTIVE EQUIPMENT TO KEEP VAPOR CONC BELOW TLV.
Other Protective Equipment:EMERGENCY EYEWASH & DELUGE SHOWER MEETING
    ANSI DESIGN CRITERIA . SOLVENT RESISTANT APRONS ARE RECOMMENDED.
Work Hygienic Practices:USE OF CONT LENSES IS NOT REC. SMOKE IN
    DESIGNATED AREAS ONLY. WASH W/SOAP & WATER BEFORE EATING,
Supplemental Safety and Health
EFTS OF OVEREXP: REPRO DISORDERS & BIRTH DEFECTS. "INORG LEAD & CERTAIN
    CHROMIUM CMPDS" IS INCLUDED IN NTP & IARC LISTS OF CARCINS. EXCESS
    EXPOS TO CRYSTALLINE SILICA IS ALSO A KNOWN CAUSE OF SILICOSI S, A
    NON-CANCEROUS LUNG DISEASE. OVEREXP SHOULD NOT OCCUR DURING NORM
*  Product Identification  *
*  Composition/Information on Ingredients  *
Ingred Name:SOLVENT NAPHTHA (PETROLEUM) MEDIUM ALIPHATIC; (PETROLEUM
Ingred Name:BARIUM SULFATE
Ingred Name:PIGMENTS (MIXTURE)
EPA Rpt Qty:1 LB
DOT Rpt Qty:1 LB
Ingred Name:ALIPHATIC PETROLEUM DISTILLATE; (PETROLEUM DISTILLATE;
ACGIH TLV:N/K 
Ingred Name:PETROLEUM HYDROCARBON; (PETROLEUM DISTILLATE; ALIPHATIC
Fraction by Wt: 0-5%
Fraction by Wt: 0-2%
OSHA PEL:0.5 MG/M3
ACGIH TLV:0.5 MG (SB)/M3
Ingred Name:HEAVY AROMATIC NAPHTHA (SOLVENT NAPHTHA); (PETROLEUM
Fraction by Wt: 0-2%
ACGIH TLV:N/K 
Fraction by Wt: <5%
OSHA PEL:1 MG/M3
ACGIH TLV:0.5 MG/M3
EPA Rpt Qty:1 LB
DOT Rpt Qty:1 LB
Ingred Name:SILICA, CRYSTALLINE - CRISTOBALITE; (CRYSTALLINE SILICA)
Fraction by Wt: <1%
OSHA PEL:SEE TABLE Z-3
Fraction by Wt: <1%
OSHA PEL:0.1 MG/M3
OSHA PEL:N/K 
ACGIH TLV:N/K 
Ingred Name:SUP DAT:OVEREXP TO SOLV W/PERM BRAIN & NERV SYS DMG.
    HAZARD LIST INFO & SAFE HANDLING & EXPOSURE INFO .
Ingred Name:EXPLAN OF CARCIN: SILICA, CRYSTALLINE-CRISTOBALITE: IARC
    ANTICIPATED TO BE CARCINOGEN.
Ingred Name:HYGIENE PRACT: TOILET FACILITIES. REMOVE CONTAMINATED
    CLOTHING TO PREVENT PROLONGED SKIN CONTACT.
*  Hazards Identification  *
Routes of Entry: Inhalation:YES  Skin:YES  Ingestion:YES
Reports of Carcinogenicity:NTP:YES    IARC:YES  OSHA:NO
Health Hazards Acute and Chronic:ACUTE: EYE: MAY CAUSE MOD TO SEV IRRIT
    INCL BURNING, TEARING, SWELL & REDNESS. RPTD & PRLNG SKIN CONT MAY
    CAUSE SLIGHT IRRIT/MILD DERM CHARACTERIZED BY DRYNESS, CHAPPING &
    REDNESS. RPTD/PRLNG SKIN CON T MAY CAUSE BURNS TO SKIN. OVEREXP BY
    INHAL MAY CAUSE RESP TRACT IRRIT/NERV SYS DISORDERS SUCH AS (EFTS
    OF OVEREXP)
Explanation of Carcinogenicity:COBALT: IARC MONO ON EVALUATION OF
Effects of Overexposure:HLTH HAZ: HDCH, DIZZ, WEAK & FATG. INGEST MAY
    CAUSE ABDOM PAIN, NAUS & DIARR, VOMIT. ASPIR OF MATL INTO LUNGS MAY
    CAUSE CHEM PNEUMIT WHICH CAN BE FATAL. RPTD & PRLNG OVEREXP TO LEAD
    BY INGEST MAY CAUS E METALLIC TASTE IN MOUTH, NAUS,
    DIGESTDISORDERS, ABDOM CRAMPS & INSOMNIA AS WELL AS BLOOD, NERV,
    URINARY & (SUP DAT)
Medical Cond Aggravated by Exposure:PERS W/PREEXISTING SKIN/LUNG
    DISORDERS MAY BE MORE SUSCEPTIBLE TO EFTS OF THIS MATL. RPTD &
    PRLNG OVEREXP &/INDIVIDUAL SENSITIVITY MAY INCR POTENTIAL FOR &
    DEGREE OF ADVERSE HLTH EFTS.
*  First Aid Measures  *
First Aid:SKIN: WASH WITH SOAP AND WATER, CONTACT MD IF IRRITATION
    MINUTES, CONTACT MD IF IRRITATION PERSISTS. INHALATION: REMOVE TO
    FRESH AIR, REST ORE BREATHING, CONTACT MD. INGESTION: CONTACT MD OR
    POISON CONTROL CENTER IMMEDIATELY.
*  Fire Fighting Measures  *
Flash Point Method:SCC
Lower Limits:1.0%
Extinguishing Media:USE FOAM, CARBON DIOXIDE, DRY CHEMICAL, WATER
    SPRAY.
Fire Fighting Procedures:WEAR NIOSH/MSHA APPROVED SCBA & FULL
    PROTECTIVE EQUIPMENT . WATER MAY BE INEFFECTIVE BUT MAY BE USED TO
    COOL CONTAINERS.
Unusual Fire/Explosion Hazard:ISOLATE FROM HEAT, ELECTRICAL EQUIPMENT,
    SPARKS, AND OPEN FLAME. CLOSED CONTAINERS MAY EXPLODE WHEN EXPOSED
    TO EXTREME HEAT.
*  Accidental Release Measures  *
Spill Release Procedures:REMOVE ALL SOURCES OF IGNITION. VENTILATE
    AREA. AVOID BREATHING VAPORS. CONTAIN RELEASE AND REMOVE WITH INERT
    ABSORBENT. AVOID CONTACT. USE NON-SPARKING TOOLS TO PLACE MATERIAL
    IN APPROPRIATE CONTAINE R FOR DISPOSAL.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
*Handling and Storage  *
Handling and Storage Precautions:STORE IN CLOSED CONTAINERS IN COOL,
    DRY, WELL-VENTILATED AREA AWAY FROM SOURCES OF IGNITION. KEEP
    CONTAINERS CLOSED WHEN NOT IN USE.
Other Precautions:AVOID PROLONGED OR REPEATED OVEREXPOSURE TO THIS
    PRODUCT. EMPTY CONTAINERS SHOULD BE DISPOSED OF IN AN
    ENVIRONMENTALLY SAFE MANNER IN ACCORDANCE WITH APPLICABLE
    REGULATIONS.
*  Physical/Chemical Properties  *
Vapor Pres:SEE INGS
Vapor Density:HVR/AIR
Evaporation Rate & Reference:SLOWER THAN ETHER
Appearance and Odor:NONE SPECIFIED BY MANUFACTURER
*  Stability and Reactivity Data  *
Stability Indicator/Materials to Avoid:YES
STRONG OXIDIZING AGENTS.
Stability Condition to Avoid:HEAT, SPARKS, AND OPEN FLAME.
Hazardous Decomposition Products:CARBON MONOXIDE, CARBON DIOXIDE, AND
    OTHER NOXIOUS GASES.
*  Disposal Considerations  *
Waste Disposal Methods:DISPOSE OF IN ACCORDANCE W/APPLICABLE LOCAL,
    COUNTY, STATE & FEDERAL REGULATIONS.
